DHER34:BVMF
Danaher Corporation Bdr
R$39.51
0.00%
(0.00) 1D
Oct 5, 4:56:00 PM GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DHER34...
Open
R$38.95
High
R$39.72
Low
R$38.30
Mkt. cap
155.51B
Avg. vol.
2.47K
Volume
41.00
52-wk high
R$45.87
52-wk low
R$27.94
Shares outstanding
702.99M
No. of employees
59K
Open
R$38.95
High
R$39.72
Low
R$38.30
Mkt. cap
155.51B
Avg. vol.
2.47K
Volume
41.00
52-wk high
R$45.87
52-wk low
R$27.94
Shares outstanding
702.99M
No. of employees
59K
News stories
From web sources and news partners
GuruFocus
·
14 hours ago
Danaher Corp (DHR) Stock Up 3.3% and Still Undervalued -- GF Sco
Insider Monkey
·
16 hours ago
Danaher Has Barely Moved in a Year. Is its 25x Earnings Valuation Justified?
TradingKey
·
17 hours ago
Danaher Corp Stock (DHR) Moved Up by 3.32% on Oct 5: What Investors Need To Know
Investing.com
·
22 hours ago
RBC Capital raises Danaher stock price target on peer valuation
Profile
Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology, which develops products for the development of therapeutics; life sciences, which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics, which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing.
The company is ranked 180th on the Fortune 500 and 241st on the Forbes Global 2000. Wikipedia
About Danaher Corporation Bdr